Logo
x

Search

Subscribe Now

 Regulatory

PharmaShots Weekly Snapshots (December 16 – December 20, 2024)

PharmaShots Weekly Snapshots (December 16 – December 20, 2024)

  • December 20, 2024
Lantern Pharma's LP-184 Gains the US FDA’s Fast-Track Designation to Treat TNBC

Lantern Pharma's LP-184 Gains the US FDA’s Fast-Track Designation to Treat TNBC

  • December 19, 2024
Eli Lilly Reports Kinsula (Donanemab-Azbt) Approval in China to Treat Early Symptomatic Alzheimer's Disease

Eli Lilly Reports Kinsula (Donanemab-Azbt) Approval in China to Treat Early Symptomatic Alzheimer's Disease

  • December 19, 2024
GSK’s GSK’227 Secures the EMA’s Priority Medicines (PRIME) Designation for Extensive-Stage Small-cell Lung Cancer

GSK’s GSK’227 Secures the EMA’s Priority Medicines (PRIME) Designation for Extensive-Stage Small-cell Lung Cancer

  • December 19, 2024
ViiV Healthcare Reports the CHMP’s Positive Opinion of Vocabria Plus Rekambys for HIV treatment

ViiV Healthcare Reports the CHMP’s Positive Opinion of Vocabria Plus Rekambys for HIV treatment

  • December 18, 2024
Merck Reports the US FDA’s BLA Acceptance of Clesrovimab to Protect Infants from RSV Disease

Merck Reports the US FDA’s BLA Acceptance of Clesrovimab to Protect Infants from RSV Disease

  • December 18, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.